Your browser is no longer supported. Please, upgrade your browser.
Surmodics, Inc.
Index- P/E156.87 EPS (ttm)0.30 Insider Own3.10% Shs Outstand13.84M Perf Week0.49%
Market Cap642.84M Forward P/E- EPS next Y-1.00 Insider Trans-7.83% Shs Float13.55M Perf Month3.98%
Income4.20M PEG15.69 EPS next Q-0.32 Inst Own90.70% Short Float1.87% Perf Quarter-14.28%
Sales105.10M P/S6.12 EPS this Y272.50% Inst Trans- Short Ratio4.79 Perf Half Y-11.31%
Book/sh10.12 P/B4.65 EPS next Y32.00% ROA2.40% Target Price72.50 Perf Year7.00%
Cash/sh2.85 P/C16.53 EPS next 5Y10.00% ROE3.00% 52W Range42.47 - 62.27 Perf YTD-2.26%
Dividend- P/FCF63.65 EPS past 5Y-16.70% ROI3.10% 52W High-27.69% Beta1.03
Dividend %- Quick Ratio2.10 Sales past 5Y8.10% Gross Margin83.70% 52W Low6.03% ATR1.50
Employees389 Current Ratio2.40 Sales Q/Q6.70% Oper. Margin6.40% RSI (14)40.22 Volatility2.85% 3.11%
OptionableYes Debt/Eq0.07 EPS Q/Q90.40% Profit Margin4.00% Rel Volume0.72 Prev Close47.06
ShortableYes LT Debt/Eq0.00 EarningsNov 10 BMO Payout0.00% Avg Volume52.90K Price45.03
Recom1.50 SMA20-5.08% SMA50-5.33% SMA200-15.46% Volume38,162 Change-4.31%
Jul-23-20Upgrade Needham Hold → Buy
Dec-11-19Downgrade Needham Buy → Hold
Nov-01-19Downgrade Lake Street Buy → Hold $75 → $50
Aug-01-19Reiterated Needham Buy $65 → $68
May-02-19Reiterated Needham Buy $74 → $65
May-02-19Reiterated Lake Street Buy $90 → $75
Feb-21-19Reiterated Needham Buy $69 → $74
May-16-18Reiterated Needham Buy $46 → $55
Mar-01-18Upgrade Sidoti Neutral → Buy
Feb-28-18Reiterated Lake Street Buy $35 → $38
Feb-28-18Initiated Needham Buy $42
Jul-14-17Initiated Lake Street Buy $40
Nov-21-16Downgrade Barrington Research Outperform → Mkt Perform
Oct-06-16Downgrade Sidoti Buy → Neutral
May-03-16Reiterated Barrington Research Outperform $27 → $30
Aug-06-15Reiterated Barrington Research Outperform $28 → $29
Mar-27-15Initiated Dougherty & Company Buy $33
Feb-25-14Initiated Laidlaw Buy $30
Aug-01-13Upgrade Feltl & Co. Buy → Strong Buy $31.25
Nov-12-12Reiterated Barrington Research Outperform $20 → $22
Jan-18-22 07:30AM  
Jan-11-22 08:35AM  
Jan-05-22 07:00AM  
Dec-30-21 09:57AM  
Nov-24-21 07:37AM  
Nov-12-21 09:36AM  
Nov-10-21 04:31PM  
Nov-02-21 08:30AM  
Oct-27-21 03:03PM  
Oct-19-21 01:59PM  
Oct-05-21 07:57AM  
Sep-29-21 08:15AM  
Sep-13-21 12:46PM  
Aug-26-21 11:40AM  
Aug-10-21 11:40AM  
Aug-07-21 04:12AM  
Aug-05-21 10:31AM  
Aug-04-21 03:01PM  
Jul-29-21 08:30AM  
Jul-28-21 03:03PM  
Jul-27-21 08:30AM  
Jul-19-21 11:40AM  
Jul-13-21 06:51AM  
Jul-07-21 07:02AM  
Jul-06-21 08:05AM  
Jul-02-21 11:40AM  
Jun-10-21 06:22AM  
May-19-21 11:40AM  
May-11-21 09:38AM  
Apr-29-21 01:31PM  
Apr-28-21 01:30PM  
Apr-20-21 08:30AM  
Apr-12-21 12:33PM  
Apr-07-21 11:40AM  
Apr-06-21 01:07PM  
Apr-01-21 08:42AM  
Mar-31-21 12:26PM  
Mar-30-21 12:19PM  
Mar-23-21 07:30PM  
Mar-17-21 04:05PM  
Mar-16-21 12:20PM  
Feb-10-21 11:31AM  
Feb-09-21 04:00PM  
Feb-05-21 08:12AM  
Feb-04-21 08:30AM  
Feb-02-21 12:31PM  
Feb-01-21 08:30AM  
Jan-25-21 08:25AM  
Jan-20-21 11:40AM  
Jan-12-21 08:05AM  
Dec-16-20 10:28AM  
Dec-04-20 11:31AM  
Nov-09-20 08:05AM  
Nov-05-20 09:13AM  
Nov-04-20 06:05PM  
Oct-28-20 12:32PM  
Oct-27-20 08:30AM  
Oct-22-20 12:33PM  
Oct-12-20 11:40AM  
Sep-29-20 09:06AM  
Sep-23-20 08:30AM  
Sep-15-20 08:20AM  
Sep-04-20 11:31AM  
Aug-10-20 08:17AM  
Aug-07-20 11:39AM  
Aug-05-20 06:15PM  
Jul-29-20 12:33PM  
Jul-28-20 08:30AM  
Jul-22-20 12:32PM  
Jul-14-20 11:40AM  
Jul-08-20 08:39AM  
Jul-05-20 05:45PM  
Jul-01-20 08:49AM  
Jun-30-20 06:57AM  
Jun-29-20 10:12AM  
Jun-26-20 09:09AM  
Jun-25-20 07:53AM  
Jun-23-20 09:24AM  
Jun-17-20 06:28AM  
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stich Joseph J.SVP, HR and GM, IVDJan 04Sale50.002,500125,00045,839Jan 06 04:15 PM
BEDOYA JOSE HDirectorNov 30Option Exercise21.315,576118,82528,393Dec 01 10:28 AM
BEDOYA JOSE HDirectorNov 30Sale44.005,576245,35022,817Dec 01 10:28 AM
DANTZKER DAVIDDirectorNov 24Sale47.013,475163,36030,821Nov 29 04:28 PM
DANTZKER DAVIDDirectorNov 03Option Exercise21.315,576118,82536,397Nov 08 09:55 AM
Maharaj Gary RPresident & CEONov 01Sale54.656,000327,904146,811Nov 02 05:49 PM
Maharaj Gary RPresident & CEOOct 01Sale56.026,000336,097152,811Oct 05 04:01 PM
Maharaj Gary RPresident & CEOSep 15Sale57.236,000343,359158,811Sep 17 04:04 PM
Arens Timothy J.Chief Financial OfficerAug 31Option Exercise23.9512,498299,32769,996Sep 01 04:20 PM
OLSON CHARLES WSenior VP of Bus Dev, Med DevAug 31Sale59.751,29277,19739,292Sep 01 04:20 PM
Stich Joseph J.SVP, HR and GM, IVDAug 24Option Exercise21.0314,276300,22456,552Aug 26 04:12 PM
Stich Joseph J.SVP, HR and GM, IVDAug 19Sale54.402,500136,00242,276Aug 23 11:38 AM
Manders John D.Corporate ControllerAug 11Option Exercise22.952,60859,8545,716Aug 13 10:13 AM
Manders John D.Corporate ControllerAug 11Sale53.352,608139,1363,108Aug 13 10:13 AM
KALICH RONALD B SRDirectorAug 06Option Exercise21.314,43094,40326,681Aug 10 04:37 PM
Stich Joseph J.SVP, HR and GM, IVDMay 20Sale53.802,500134,50645,776May 24 08:49 AM
OLSON CHARLES WSenior VP of Bus Dev, Med DevApr 28Sale59.751,50890,10340,584Apr 30 09:53 AM
OLSON CHARLES WSenior VP of Bus Dev, Med DevApr 16Sale59.7564838,71842,092Apr 20 04:15 PM
OLSON CHARLES WSenior VP of Bus Dev, Med DevMar 31Sale56.754,759270,07342,740Apr 02 02:30 PM
Maharaj Gary RPresident & CEOMar 01Sale52.064,000208,259164,713Mar 03 06:12 PM
KNIGHT SUSAN EDirectorFeb 26Option Exercise21.315,576118,82534,290Mar 02 04:06 PM
OLSON CHARLES WSenior VP of Bus Dev, Med DevFeb 26Option Exercise20.4613,533276,82756,638Mar 02 04:07 PM
KNIGHT SUSAN EDirectorFeb 26Sale52.365,576291,95528,714Mar 02 04:06 PM
Arens Timothy J.Chief Financial OfficerFeb 24Option Exercise20.4410,973224,24265,076Feb 26 04:02 PM
BEDOYA JOSE HDirectorFeb 23Sale50.681,49775,86822,817Feb 25 04:33 PM
Stich Joseph J.SVP, HR and GM, IVDFeb 16Sale51.692,500129,23748,062Feb 18 04:37 PM
KALICH RONALD B SRDirectorFeb 12Option Exercise26.464,098108,43323,504Feb 16 04:50 PM
Maharaj Gary RPresident & CEOFeb 11Option Exercise22.3682,2641,839,571224,406Feb 16 04:52 PM
Maharaj Gary RPresident & CEOFeb 01Sale44.813,000134,423142,142Feb 03 04:14 PM